Form 4 Tracker
Katherine Stueland

Director, CHIEF EXECUTIVE OFFICER · 7 filings · Latest: Apr 29, 2026

GeneDx Holdings Corp.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
WGS
Katherine StuelandDirector, CHIEF EXECUTIVE OFFICERApr 29, 2026
Sale
$65.192,172$141.6K93,216
WGS
Katherine StuelandDirector, CHIEF EXECUTIVE OFFICERApr 29, 2026
Option Exercise
$0.003,87495,388
WGS
Katherine StuelandApr 29, 2026
Proposed Sale
$63.2016,415$1.0M
WGS
Katherine StuelandDirector, CHIEF EXECUTIVE OFFICERMar 26, 2026
Sale
$63.1746,933$3.0M91,514
WGS
Katherine StuelandDirector, CHIEF EXECUTIVE OFFICERMar 26, 2026
Option Exercise
$0.0080,000138,447
WGS
Katherine StuelandDirector, CHIEF EXECUTIVE OFFICERMar 16, 2026
Sale
$76.8017,179$1.3M58,447
WGS
Katherine StuelandDirector, CHIEF EXECUTIVE OFFICERMar 16, 2026
Option Exercise
$0.0018,75075,626
WGS
Katherine StuelandDirector, CHIEF EXECUTIVE OFFICERMar 15, 2026
Option Exercise
$0.0011,92156,876
WGS
Katherine StuelandDirector, CHIEF EXECUTIVE OFFICERMar 9, 2026
Sale
$86.753,678$319.1K44,955
WGS
Katherine StuelandDirector, CHIEF EXECUTIVE OFFICERMar 9, 2026
Option Exercise
$0.006,54648,633
WGS
Katherine StuelandDirector, CHIEF EXECUTIVE OFFICERMar 4, 2026
Sale
$78.6125,459$2.0M38,683
WGS
Katherine StuelandDirector, CHIEF EXECUTIVE OFFICERJan 29, 2026
Sale
$94.001,653$155.4K16,458
WGS
Katherine StuelandDirector, CHIEF EXECUTIVE OFFICERJan 29, 2026
Option Exercise
$0.003,87418,111
WGS
Katherine StuelandJan 29, 2026
Proposed Sale
$98.0994,495$9.3M
WGS
Katherine StuelandSep 30, 2025
Proposed Sale
$107.9329,283$3.2M
WGS
Katherine StuelandJul 1, 2025
Proposed Sale
$91.9329,302$2.7M
WGS
Katherine StuelandJun 9, 2025
Proposed Sale
$72.5514,139$1.0M
WGS
Katherine StuelandApr 29, 2025
Proposed Sale
$113.092,154$243.6K
WGS
Stueland KatherineApr 9, 2025
Proposed Sale
$87.9946,594$4.1M
WGS
Katherine StuelandMar 26, 2025
Proposed Sale
$95.6246,551$4.5M

Page 1 of 2

Next →